BioVie Inc. (BIVI) — Financial statements
Income statement, balance sheet, and cash flow for BioVie Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.23 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 9↓59.9% | 23↓30.6% | 33↑92.9% | 17↓87.0% | 133 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 9 | 0.00↓100.0% | 12 | 0.00 | 0.00 | |
| Other Expenses | 0.00↓100.0% | 9↑3858.2% | 0.23↓97.7% | 10↑105.4% | 5 | |
| Operating Expenses | 18↓44.6% | 32↓28.6% | 45↑65.4% | 27↓80.3% | 138 | |
| Total Costs & Expenses | 18↓43.9% | 32↓28.6% | 45↑65.4% | 27↓80.3% | 138 | |
| Operating Results | ||||||
| Operating Income | -18↑43.9% | -32↑28.6% | -45↓65.4% | -27↑80.3% | -138 | |
| Depreciation & Amortization | 0.23↑0.0% | 0.23↑0.0% | 0.23↑0.0% | 0.23↓0.3% | 0.23 | |
| EBITDA | -18↑44.2% | -32↑30.1% | -46↓69.2% | -27↑80.4% | -138 | |
| EBIT | -18↑43.9% | -32↑30.0% | -46↓68.6% | -27↑80.3% | -138 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.52↑129.6% | -2↑53.0% | -4↓76.4% | -2↓294.2% | -0.54 | |
| Interest Income | 0.85↓25.0% | 1↑102.2% | 0.56↑1175.6% | 0.04↑100.6% | 0.02 | |
| Interest Expense | 0.33↓88.5% | 3↓32.7% | 4↑98.8% | 2↑286.6% | 0.56 | |
| Non-Operating Income | 0.00 | 0.00↓100.0% | 0.88 | 0.00 | 0.00 | |
| Other Income / Expenses | 0.52↑787.5% | 0.06↑101.1% | -5↓542.9% | 1↓85.0% | 8 | |
| Income Before Tax | -18↑45.4% | -32↑36.1% | -50↓92.7% | -26↑80.0% | -130 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -18↑45.4% | -32↑36.1% | -50↓92.7% | -26↑80.0% | -130 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -18↑45.4% | -32↑36.1% | -50↓92.7% | -26↑80.0% | -130 | |
| Bottom-Line Net Income | -18↑45.7% | -33↑34.3% | -50↓92.7% | -26↑85.8% | -184 | |
| EPS (Basic) | -12.12↑83.4% | -73.05↑52.8% | -154.70↓45.9% | -106.00↑92.8% | -1,482.30 | |
| EPS (Diluted) | -12.12↑83.4% | -73.05↑52.8% | -154.70↓45.9% | -106.00↑92.8% | -1,482.30 | |
| Weighted Average Shares | 1↑227.0% | 0.45↑39.1% | 0.32↑31.7% | 0.25↑98.8% | 0.12 | |
| Weighted Average Diluted Shares | 1↑227.0% | 0.45↑39.1% | 0.32↑31.7% | 0.25↑98.8% | 0.12 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.